Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis

Lancet Gastroenterol Hepatol. 2025 Jan;10(1):18-19. doi: 10.1016/S2468-1253(24)00379-0.

Authors

Yannick Hoffert¹, Marc Ferrante², Bram Verstockt², Erwin Dreesen³

Affiliations

¹ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven 3000, Belgium.
² TARGID, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium; Department of Gastroenterology and Hepatology, UZ Leuven, KU Leuven, Leuven, Belgium.
³ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven 3000, Belgium. Electronic address: erwin.dreesen@kuleuven.be.

PMID: 39674216
DOI: 10.1016/S2468-1253(24)00379-0

No abstract available

Publication types

Letter